KRISTEN VELSMID: Open Payments
NPI 1275806390 · SOUTHBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 8 payments from 6 companies in 2025. Trend: 2023 $125 · 2024 $0 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $122 |
| Alnylam Pharmaceuticals Inc. | 1 | $82 |
| Amgen Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Novo Nordisk Inc | 1 | $26 |
Products named: TREMFYA, AMVUTTRA, Repatha, LEQVIO, ELIQUIS, Wegovy.
Industry payments across CT — which companies pay providers there.
